Kidswell Bio (TSE:4584) Other Stockholders Equity: 円137 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4584 Kidswell Bio Corp TSE:4584
44 GF Score
Price 円151.00
GF Value 円231.66
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Kidswell Bio Other Stockholders Equity?

Kidswell Bio TSE:4584 +0.67% 44 Other Stockholders Equity is 円137 Mil as of Mar. 2026. GuruFocus rates TSE:4584 with a GF Score™ of 44/100 and a GF Value™ of 円231.66 (Possible Value Trap). The stock has 8 warning signs investors should review.

Kidswell Bio's Other Stockholders Equity for the quarter that ended in Mar. 2026 was 円137 Mil.

Kidswell Bio's quarterly Other Stockholders Equity increased from Mar. 2025 (円201 Mil) to Sep. 2025 (円208 Mil) but then declined from Sep. 2025 (円208 Mil) to Mar. 2026 (円137 Mil).

Kidswell Bio's annual Other Stockholders Equity increased from Mar. 2024 (円162 Mil) to Mar. 2025 (円201 Mil) but then declined from Mar. 2025 (円201 Mil) to Mar. 2026 (円137 Mil).

Kidswell Bio Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Kidswell Bio's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kidswell Bio Other Stockholders Equity Chart

Kidswell Bio Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 184.53 195.99 161.58 200.52 137.16

Kidswell Bio Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 161.58 183.47 200.52 207.91 137.16
TSE:4584
44GF Score
Kidswell Bio Corp TSE:4584
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kidswell Bio Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of 円137 Mil mean?
Kidswell Bio (TSE:4584) has a Other Stockholders Equity of 円137 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Kidswell Bio and its competitors.
Is Kidswell Bio's Other Stockholders Equity too high?
Kidswell Bio's current Other Stockholders Equity is 円137 Mil. Overall, Kidswell Bio has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kidswell Bio's Other Stockholders Equity compare to VRTX and REGN?
Kidswell Bio's Other Stockholders Equity of 円137 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Kidswell Bio and its competitors. Kidswell Bio's current Other Stockholders Equity is 円137 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kidswell Bio stock overvalued right now?
Based on GuruFocus' analysis, Kidswell Bio (TSE:4584) is currently considered Possible Value Trap. The stock's GF Value™ is 円231.66, compared to a current price of 円151.00 — trading 34.8% below its estimated fair value. The current Other Stockholders Equity is 円137 Mil. Kidswell Bio's overall GF Score™ is 44/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Kidswell Bio (TSE:4584), the current Other Stockholders Equity is 円137 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kidswell Bio (TSE:4584) Overvalued in 2026?

Based on GuruFocus' analysis, Kidswell Bio stock appears to be undervalued. The current stock price of 円151.00 is trading 34.8% below its estimated GF Value™ of 円231.66. GuruFocus considers Kidswell Bio to be Possible Value Trap.

Key valuation signals for TSE:4584:

  • Other Stockholders Equity: 円137 Mil
  • GF Value™: 円231.66 vs. price of 円151.00 (34.8% below fair value)
  • GF Score™: 44/100 with 8 warning signs

No single metric tells the full story. See the TSE:4584 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kidswell Bio Business Description

Address 1-2-12, Shinkawa, Kanayama Building, 3rd Floor, Chuo-ku, Tokyo, JPN, 104-0033
Kidswell Bio Corp is a biopharmaceutical company engaged in the discovery and development of drugs.
44GF Score

Get the complete analysis for TSE:4584

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円151.00
Price
円231.66
GF Value